Geiger Uri 4

What Happened Uri Geiger, a member of NeuroPace's board of directors, was issued 913 shares on 2026-03-20 at a reported price of $13.00 per share, valued at $11,869. The Form 4 lists this transaction as an award/grant (code A) — shares issued in lieu of quarterly retainer fees under the issuer's non-employee director compensation policy.

Key Details

• Transaction date and price: 2026-03-20, 913 shares at $13.00 each (total $11,869).
• Filing date: Form 4 filed 2026-03-24 (filed within the SEC’s two-business-day window for Form 4s).
• Shares owned after transaction: Not specified in the filing.
• Footnotes:
  • F1: Shares issued pursuant to the non-employee director compensation policy in lieu of quarterly retainer fees.
  • F2: Shares are held by Accelmed Partners II LP; Uri Geiger has sole voting and dispositive power through his role with Accelmed entities (he is a General Partner at Accelmed LLC).

Context This was an equity award for director compensation, a routine non-cash issuance rather than an open-market purchase or sale. Such grants are common for non-employee directors and should be viewed as compensation rather than a direct buy/sell signal about the insider’s market view.